China Universal Asset Management Company’s Rocket Pharmaceuticals RCKT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$69K Buy
19,266
+1,631
+9% +$6.48K 0.01% 441
2025
Q4
$61.9K Sell
17,635
-1,279
-7% -$4.38K ﹤0.01% 440
2025
Q3
$61.7K Sell
18,914
-2,725
-13% -$8.58K 0.01% 417
2025
Q2
$53K Buy
21,639
+251
+1% +$1.27K 0.01% 414
2025
Q1
$143K Buy
21,388
+2,059
+11% +$20.3K 0.01% 338
2024
Q4
$243K Buy
19,329
+1,824
+10% +$27.5K 0.02% 314
2024
Q3
$323K Buy
17,505
+6,839
+64% +$140K 0.04% 263
2024
Q2
$230K Sell
10,666
-6,699
-39% -$154K 0.03% 222
2024
Q1
$468K Buy
17,365
+6,941
+67% +$197K 0.06% 188
2023
Q4
$312K Buy
10,424
+8,356
+404% +$184K 0.06% 173
2023
Q3
$42.4K Buy
2,068
+1,014
+96% +$18.4K 0.01% 239
2023
Q2
$20.9K Sell
1,054
-21
-2% -$424 0.01% 264
2023
Q1
$18.4K Buy
1,075
+306
+40% +$5.99K 0.01% 228
2022
Q4
$15K Buy
769
+151
+24% +$2.78K 0.01% 197
2022
Q3
$10K Buy
+618
New +$9.64K ﹤0.01% 208

Other funds holding RCKT